SNU-719 Cells

Unit

3 x 10^6 cells/ml

Cell Type

Tumor Cells

Tissue Type

Gastric cancer cell lines

Organism

Human

Donor History

tubular adenocarcinoma

Growth Properties

Adherent

,

monolayer

Growth Conditions

Culture medium: RPMI 1640

,

w: 2.0 mM stable Glutamine

,

w: 2.0 g/L NaHCO3 (Cytion article number 820700a). Supplements: Supplement the medium with 10% FBS. Dissociation reagent: Accutase. Freeze medium: As a cryopreservation medium

,

we use complete growth medium (including FBS) + 10% DMSO for adequate post-thaw viability

,

or CM-1 (Cytion catalog number 800100)

,

which includes optimized osmoprotectants and metabolic stabilizers to enhance recovery and reduce cryo-induced stress. Incubation atmosphere: 37°C

,

5% CO2

,

humidified atmosphere.

Immortalization Method
Full Information

https://www.cytion.com/SNU-719-Cells/305636

SKU: 305636 Kategorie: ,
Mgr. Otakar Fišer
Máte otázky k tomuto produktu? Kontaktujte našeho specialistu.
Mgr. Otakar Fišer
Produktový manažer - Life Science
Popis

The SNU-719 cell line is a human gastric carcinoma model established from the primary gastric tumor tissue of an adult male patient in Korea. It belongs to a collection of gastric cancer lines developed to support cancer research in East Asia, where gastric cancer prevalence is particularly high. SNU-719 was derived from a moderately differentiated adenocarcinoma and has demonstrated strong attachment to plastic culture surfaces, growing as a diffuse monolayer. The line was maintained in RPMI-1640 medium supplemented with 10% heat-inactivated fetal bovine serum.

Comprehensive biochemical and genetic profiling of SNU-719 revealed expression of carcinoembryonic antigen (CEA) and high levels of tissue polypeptide antigen (TPA) in both supernatant and cell lysate. However, alpha-fetoprotein (aFP) was not detected. Mutation analysis identified alterations in the TP53 gene, although the c-Ki-ras oncogene remained unmutated in this line. These features make SNU-719 a suitable model for studying the molecular mechanisms of gastric adenocarcinoma and for evaluating biomarker expression and therapeutic interventions. Additionally, STR and SNP profiling have confirmed its identity and uniqueness, ensuring the cell line’s reliability for in vitro experimentation.

O značce

Společnost Cytion vznikla v roce 2004 v německém Heidelbergu s jasným vědeckým posláním: dodávat ověřené lidské a zvířecí buněčné linie bez kontaminace, připravené za přísně kontrolovaných laboratorních podmínek.

Postupně se vypracovala ve spolehlivou buněčnou banku, která slouží akademickým laboratořím, biotechnologickým firmám i farmaceutickým výzkumným týmům po celém světě. Klade přitom důraz na reprodukovatelnost výsledků, přísnou kontrolu kvality a dlouhodobá partnerství.